A Phase 2 Open Label, Single-Arm Trial to Evaluate the Combination of Cetuximab Plus Taxotere, Cisplatin, and 5-Flurouracil as an Induction Regimen in Patients with Unresectable Squamous Cell Carcinoma of the Head and Neck

1. Mesía, R.
2. Vázquez, S.
3. Grau, J.J.
4. García-Sáenz, J.A.
5. Lozano, A.
6. García, C.
7. Carles, J.
8. Irigoyen, A.
9. Mañós, M.
10. García-Paredes, B.
11. Del Barco, E.
12. Taberna, M.
13. Escobar, Y.
14. Cruz, J.J.